MedPath

Clinical and mobidity profile in patients of â??semirigid ureteroscopy for ureteric calculiâ??

Not Applicable
Conditions
Health Condition 1: N201- Calculus of ureter
Registration Number
CTRI/2021/01/030285
Lead Sponsor
niversity College of Medical Sciences University of Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of age 18-80 years who underwent semirigid URS for ureteric calculi in last 10 years from 30.10.2009 to 30.10.2019 for retrospective study as well as new consenting cases of â??ureteric stones with semirigid URSâ?? for prospective study will be enrolled. After Institutional ethical committee clearance and a telephonic/written and informed bilingual consent eligible patients will be counselled for enrolment into this study.

2.MRD case records will be used to enrol the patients.

Exclusion Criteria

Exclusion criteria

For retrospective study:

1. Patients who had undergone ureteroscopy for conditions other than ureteric stone in past .

2.Patients with incomplete medical records.

For prospective study

3. Patients with symptoms of active/untreated UTI.

4. Patients with any contraindications for semirigid URS eg. Bleeding diathesis etc.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the prevalence, demographic profile, clinical features & perioperative morbidity in patients who have undergone â??semirigid ureteroscopy for ureteric calculiâ?? by retrospective review of case cohort of last 10 years (30.10.2009 to 30.10.2019). <br/ ><br> <br/ ><br>Timepoint: 1. Time till discharge <br/ ><br>2. 30 days post discharge (Readmission) <br/ ><br>3. 6 Weeks post discharge
Secondary Outcome Measures
NameTimeMethod
1. To study the incidence, demographic profile, clinical features &perioperative morbidity in patients of â??semirigid ureteroscopy for ureteric stonesâ?? in prospective cases subject to resumption of non covid facility and fresh IEC approval. <br/ ><br>2. To study and review the possible risk factors/comorbidities if any which can influence the occurrence of complications in patients who of â??semirigid URS for ureteric calculiâ?? <br/ ><br>Timepoint: 1. Time till discharge <br/ ><br>2. 30 days post discharge (Readmission) <br/ ><br>3. 6 Weeks post discharge
© Copyright 2025. All Rights Reserved by MedPath